June 9th, 2025 “EURETINA-Brief”© Issue No. 318
Dear EURETINA Members, A very warm welcome to the June 9th, 2025 edition of EURETINA’s web-based digital periodical, “EURETINA Brief”. EURETINA are delighted to continue…
EURETINA’s
DIGITAL
NEWSLETTER
Featured Articles
1
June 9th, 2025
Latest News
June 9th, 2025 “EURETINA-Brief”© Issue No. 318
Dear EURETINA Members, A very warm welcome to the June 9th, 2025 edition of EURETINA’s…
Research published in The Lancet, the New England Journal of Medicine, and the Journal of the American Medical Association may be barred by the US Department of Health & Human Services (HHS).
Mr. Robert F. Kennedy Jr., United States Secretary of Health & Human Services (HHS), has…
Phase 3 trial of vorolanib intravitreal insert, using a tyrosine kinase inhibitor (TKI), will be evaluating for wet age-related macular degeneration (wet AMD).
A Phase 3 randomised clinical trial has recruited of >400 patients in a seven-month period,…
First predictive AI tool for retinal therapy planning receives a European CE-mark (Class IIa) by deepeye Medical (Munich).
An innovative biomedical company, deepeye Medical GmbH, based in Munich Germany, has received a regulatory…